HIPAA UF Institutional Review Board
IRB-HIPAA NAVIGATION BAR

HIPAA Home

HIPAA Forms

HIPAA Training
HIPAA News
HIPAA FAQ
Questions?
Links
HIPAA & WIRB

IRB-01 Home
IRB-03 Home
 
Search IRB:

Quick Links:

How can we identify and/or recruit subjects?

If you are already directly involved in a patient's standard medical treatment, you do not need to do anything special to approach him/her about your study. However, if this is not the case, there are certain steps which must be followed in order to legally identify and recruit subjects. Our Identifying and Recruiting Research Subjects table presents several of the most common methods of identifying and recruiting subjects, what you need to do in order to use the method within federal regulations, as well as what NOT to do when identifying & recruiting subjects.

A patient of another physician is participating in my research study. Can I report any lab results or other research related results to the treating physician, particularly if the results might be relevant to the patient/research subject's routine treatment? What if the treating physician is not part of Shands/UF or the VA?

Sharing information solely for the purposes of treatment is not strictly considered a disclosure of PHI, regardless of whether the information is generated as part of normal treatment or research. As such, a HIPAA authorization would not be required to share the information with the treating physician, regardless of whether the physician is part of your hospital or not. If the research subject is only seeing you for research purposes (i.e. not part of a clinic or hospital visit), then the subject must be provided with a copy of the hospital's or the clinic's "Notice of Privacy" before sharing any information with the treating physician.

IMPORTANT NOTE: if the PHI is being generated by a test or other measure that is investigational and not part of a CLEA approved lab, then the information alone cannot guide clinical treatment. If the results from investigational tests/measures suggest changing clinical treatment, these results must be validated by standard tests from a CLEA approved lab before treatment is altered.

Help! How do we answer the authorization questions? How specific should we get? What is meaningful?

Put yourself in the patient's position. If you were the subject/patient, what would you want to know? Specific and meaningful means you are giving the subject enough information that they understand what you are collecting/using/disclosing, who's doing this, who you're giving it to, etc. If you get too specific the information could be less meaningful, and could run into problems with having to revise the consent/authorization anytime your protocol was revised. We have taken a preliminary peek at a couple of authorizations and believe the following example does a good job of meeting the HIPAA regulations. The answers or type of answers provided in this example may not be ideal for your study - you may need to be more or less specific. This example is merely meant to serve as a starting point for you to see one way to answer the questions. Remember: how you answer the question depends on your study's content - the answers will rarely if ever be similar between any two different protocols.

What identifiers need to be removed from data in order to meet HIPAA de-identification standards?

According to the October 2002 Privacy Rule § 164.514.(b).2. page 20 the following information may not be recorded in order to meet HIPAA de-identification standards:

"(A) Names;
(B) All geographic subdivisions smaller than a State, including street address, city, county, precinct, zip code, and their equivalent geocodes, except for the initial three digits of a zip code if, according to the current publicly available data from the Bureau of the Census:

(1) The geographic unit formed by combining all zip codes with the same three initial digits contains more than 20,000 people; and
(2) The initial three digits of a zip code for all such geographic units containing 20,000 or fewer people is changed to 000.

(C) All elements of dates (except year) for dates directly related to an individual, including birth date, admission date, discharge date, date of death; and all ages over 89 and all elements of dates (including year) indicative of such age, except that such ages and elements may be aggregated into a single category of age 90 or older;
(D) Telephone numbers;
(E) Fax numbers;
(F) Electronic mail addresses;
(G) Social security numbers;
(H) Medical record numbers;
(I) Health plan beneficiary numbers;
(J) Account numbers;
(K) Certificate/license numbers;
(L) Vehicle identifiers and serial numbers, including license plate numbers;
(M) Device identifiers and serial numbers;
(N) Web Universal Resource Locators (URLs);
(O) Internet Protocol (IP) address numbers;
(P) Biometric identifiers, including finger and voice prints;
(Q) Full face photographic images and any comparable images; and
(R) Any other unique identifying number, characteristic, or code, except as permitted by paragraph (c) of this section;"

Note, it is possible for some of the elements to be included IF "a person with appropriate knowledge of and experience with generally accepted statistical and scientific principles and methods for rendering information not individually identifiable: (i) Applying such principles and methods, determines that the risk is very small that the information could be used, alone or in combination with other reasonably available information, by an anticipated recipient to identify an individual who is a subject of the information; and (ii) Documents the methods and results of the analysis that justify such determination".
(§ 164.514.(b).1. page 20).

 

 

University of Florida
  IRB-01 IRB RGP UFL HSC SPICE UF Information Security UF Privacy
          COM Clinical Trials Compliance Privacy Policy
© Univeristy of Florida
Updated: 06/22/2007 3:33 PM